Literature DB >> 26539757

Asthma Control Test and Asthma Control Questionnaire: factorial validity, reliability and correspondence in assessing status and change in asthma control.

Michael Schuler1, Hermann Faller1, Michael Wittmann2, Konrad Schultz2.   

Abstract

OBJECTIVE: This study examined the factor structures and reliabilities of the Asthma Control Test (ACT) and the Asthma Control Questionnaire (ACQ-7; ACQ-6) and the correspondence between them in assessing both level and change in asthma control.
METHODS: Lung function and questionnaire data for ACT and ACQ were assessed in 113 asthma patients at the beginning (T1) and the end (T2) of inpatient rehabilitation. Confirmatory factor analyses, composite reliability coefficients, Pearson correlations, Cohen's Kappa and positive/negative agreements were computed.
RESULTS: Unidimensional factor structure was confirmed for ACT. For ACQ configural invariance (i.e. same factor structure) over time could not be established. Furthermore, in ACQ-7, FEV1 showed no relation to the latent factor. Reliability estimates were 0.86-0.88 (ACT), 0.88-0.92(ACQ-6) and 0.81-0.86 (ACQ-7). Pearson correlations between ACT and ACQ were between 0.75 and 0.90 and tended to be higher at T2. If the aim is to identify patients with either not well-controlled asthma or change in asthma control, concordance was at least moderate (Kappa = 0.52-0.72). Correspondence tended to be lower in identifying patients with well-controlled asthma (Kappa = 0.30-0.79). In some circumstances, ACQ-6 showed higher agreement with ACT than did ACQ-7.
CONCLUSIONS: ACT is a unidimensional measure, but factor structure of ACQ remains unclear. Correspondence between ACT and ACQ depends on the aim of the assessment. Including FEV1 in the assessment of asthma control level even lowers reliability of ACQ and concordance with ACT. Our results support GINA (2014) in conceptualizing FEV1 as a risk factor for poor asthma outcome instead of an indicator of level of asthma control.

Entities:  

Keywords:  Asthma control; asthma control questionnaire; asthma control test; correspondance; factorial validity; inpatient rehabilitation; minimal important difference; reliability

Mesh:

Year:  2016        PMID: 26539757     DOI: 10.3109/02770903.2015.1101134

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  11 in total

1.  Comparing Asthma Control Questionnaire (ACQ) and National Asthma Education and Prevention Program (NAEPP) asthma control criteria.

Authors:  Hyekyun Rhee; Tanzy Love; Jennifer Mammen
Journal:  Ann Allergy Asthma Immunol       Date:  2018-09-11       Impact factor: 6.347

2.  [Clinical and inflammatory phenotypic features of asthmatic patients sensitive to cold stimulation].

Authors:  Weili Guo; Minchao Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

3.  Autophagy-Related Genes Are Involved in the Progression and Prognosis of Asthma and Regulate the Immune Microenvironment.

Authors:  Fan Yang; Jingwei Kong; Yuhan Zong; Zhuqing Li; Mingsheng Lyu; Wanyang Li; Wenle Li; Haoyue Zhu; Shunqi Chen; Xiaoshan Zhao; Ji Wang
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

4.  Depressive Symptoms and Overperception of Airflow Obstruction in Older Adults With Asthma.

Authors:  Jonathan M Feldman; Jacqueline Becker; Arushi Arora; Jesenya DeLeon; Tatiana Torres-Hernandez; Naomi Greenfield; Allyana Wiviott; Sunit Jariwala; Chang Shim; Alex D Federman; Juan P Wisnivesky
Journal:  Psychosom Med       Date:  2021-09-01       Impact factor: 3.864

5.  Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients.

Authors:  Christoph Ulrich Werner; Klaus Linde; Julia Schäffner; Constanze Storr; Antonius Schneider
Journal:  NPJ Prim Care Respir Med       Date:  2017-12-08       Impact factor: 2.871

6.  Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10).

Authors:  Christoph Ulrich Werner; Luisa Koch; Klaus Linde; Levente Kriston; Konrad Schultz; Oxana Atmann; Antonius Schneider
Journal:  NPJ Prim Care Respir Med       Date:  2018-12-04       Impact factor: 2.871

Review 7.  Bringing asthma care into the twenty-first century.

Authors:  Kjell Larsson; Hannu Kankaanranta; Christer Janson; Lauri Lehtimäki; Björn Ställberg; Anders Løkke; Kristian Høines; Klaus Roslind; Charlotte Suppli Ulrik
Journal:  NPJ Prim Care Respir Med       Date:  2020-06-05       Impact factor: 2.871

8.  Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life.

Authors:  Francesco Menzella; Matteo Fontana; Marco Contoli; Patrizia Ruggiero; Carla Galeone; Silvia Capobelli; Anna Simonazzi; Chiara Catellani; Chiara Scelfo; Claudia Castagnetti; Francesco Livrieri; Nicola Facciolongo
Journal:  J Asthma Allergy       Date:  2022-04-21

Review 9.  Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review.

Authors:  Bas C P van Dijk; Henrik Svedsater; Andreas Heddini; Linda Nelsen; Janita S Balradj; Cathelijne Alleman
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

10.  Clinical, functional and inflammatory evaluation in asthmatic patients after a simple short-term educational program: a randomized trial.

Authors:  Soraia Nogueira Felix; Rosana Câmara Agondi; Marcelo Vivolo Aun; Clarice Rosa Olivo; Francine Maria de Almeida; Thais Santos Amorim; Julia Caroline Cezario; Pedro Giavina-Bianchi; Iolanda de Fátima Lopes Calvo Tiberio; Milton de Arruda de Martins; Beatriz Mangueira Saraiva Romanholo
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.